NATIONALLetter Agreement • May 10th, 2017 • Fortress Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2017 Company Industry Jurisdiction
FORM OF COMMON STOCK PURCHASE WARRANT To Purchase [_____] Shares of Common Stock of Fortress Biotech, Inc.Common Stock Purchase Warrant • May 10th, 2017 • Fortress Biotech, Inc. • Pharmaceutical preparations
Contract Type FiledMay 10th, 2017 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (THIS “WARRANT”) CERTIFIES that, for value received, National Securities Corporation, or assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the fifth anniversary of the date hereof (the “Termination Date”) but not thereafter, to subscribe for and purchase from Fortress Biotech, Inc., a corporation incorporated in the State of Delaware (the “Company”), up to [_____] shares (the “Warrant Shares”) of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $[_____], subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Thi
FORM OF NOTE PURCHASE AGREEMENTForm of Note Purchase Agreement • May 10th, 2017 • Fortress Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2017 Company Industry JurisdictionThis NOTE PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made as of the last date set forth on the signature page hereof between FORTRESS BIOTECH, INC., a Delaware corporation having its principal place of business at 2 Gansevoort St., 9th Floor, New York, NY 10014 (the “Company”), and the undersigned (together with its successors and permitted assigns, the “Subscriber”).